MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $155,553 | -35.2% | 120,584 | -33.6% | 0.00% | -20.0% |
Q2 2023 | $239,876 | -20.6% | 181,724 | -57.5% | 0.01% | -16.7% |
Q1 2023 | $302,131 | +387.3% | 427,403 | +669.7% | 0.01% | +200.0% |
Q2 2022 | $62,000 | -32.6% | 55,532 | -32.8% | 0.00% | 0.0% |
Q1 2022 | $92,000 | -30.3% | 82,583 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $132,000 | -37.7% | 82,583 | -5.5% | 0.00% | -50.0% |
Q3 2021 | $212,000 | -47.8% | 87,420 | -31.7% | 0.01% | -53.8% |
Q2 2021 | $406,000 | -18.6% | 128,048 | -13.5% | 0.01% | -31.6% |
Q1 2021 | $499,000 | +9.0% | 148,048 | +15.6% | 0.02% | +11.8% |
Q4 2020 | $458,000 | +30.9% | 128,048 | -4.2% | 0.02% | -19.0% |
Q3 2020 | $350,000 | – | 133,634 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
F3Logic, LLC | 255 | $668,000 | 0.02% |
Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
CSS LLC/IL | 54,773 | $144,000 | 0.01% |